Reducing Medication Errors in Pneumonia Patients During Transitions of Care by Bethishou, Laressa et al.
Chapman University
Chapman University Digital Commons
Pharmacy Faculty Articles and Research School of Pharmacy
11-2017
Reducing Medication Errors in Pneumonia
Patients During Transitions of Care
Laressa Bethishou
Chapman University, bethisho@chapman.edu
Noah Fang
Lisa Shieh
Follow this and additional works at: https://digitalcommons.chapman.edu/pharmacy_articles
Part of the Health and Medical Administration Commons, Other Medicine and Health Sciences
Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Pharmacy Administration,
Policy and Regulation Commons, and the Virus Diseases Commons
This Article is brought to you for free and open access by the School of Pharmacy at Chapman University Digital Commons. It has been accepted for
inclusion in Pharmacy Faculty Articles and Research by an authorized administrator of Chapman University Digital Commons. For more information,
please contact laughtin@chapman.edu.
Recommended Citation
Bethishou L, Fang N, Shieh L. Reducing medication errors in pneumonia patients during transitions of care. California Journal of
Health-System Pharmacy. 2017;29(6):196-202.
Reducing Medication Errors in Pneumonia Patients During Transitions of
Care
Comments
This article was originally published in California Journal of Health-System Pharmacy, volume 29, issue 6, in
2017.
Copyright
California Society of Health-System Pharmacists
This article is available at Chapman University Digital Commons: https://digitalcommons.chapman.edu/pharmacy_articles/588
Requests for Information:
Laressa Bethishou, PharmD, BCPS 
bethisho@chapman.edu
O
RI
G
IN
A
L 
RE
SE
A
RC
H
196     cjhp     California Journal of Health-System Pharmacy  November/December 2017
Reducing Medication Errors 
in Pneumonia Patients During 
Transitions of Care
Laressa Bethishou, PharmD, BCPS  •  Noah Fang, PharmD, BCPS 
Lisa Shieh, MD, PhD
Purpose: At Stanford Health Care, as part of a hospital-wide initiative to reduce 
pneumonia readmission rates, an interdisciplinary collaborative effort was 
created between physicians and transitions of care (ToC) pharmacists to opti-
mize discharge planning and medication management for pneumonia patients. 
The purpose of this study was to describe the impact of the ToC pharmacist in 
identifying and reducing medication errors on discharge for pneumonia patients.
Methodology: Retrospective chart review was conducted on patients discharged 
with a pneumonia diagnosis between December 2015 to Feb 2016. Patients were 
stratified based on whether they received ToC pharmacist medication review 
vs. standard of care. Errors were identified by comparing the patient discharge 
medication list to the physician discharge summary, home, and inpatient medi-
cation lists. Errors rates were compared and stratified by error type. Pharmacist 
interventions were quantified.
Results: Of the 125 patients discharged with pneumonia, 69 patients received 
ToC pharmacist medication review, while 56 patients received standard of care. 
In the ToC intervention group, 6 errors were identified for 5 patients, which 
equates to an error rate of 7.2%. In the standard of care group, 85 medication 
errors were identified for 36 patients (64.3% error rate). The difference was statis-
tically significant (P < 0.0001) and corresponds to an 88.8% relative decrease. 
The most common error recorded was incorrect medication/dose/frequency. 
During this time, the ToC pharmacist had 71 documented interventions.
Conclusions: ToC pharmacist interventions demonstrated a clinically and statis-
tically significant decrease in medication discrepancies, as well as an increased 
rate of accuracy of the discharge medication list. Continued metrics and inter-
ventions are being collected to assess the impact of the ToC pharmacists on 
patient outcomes.
Keywords: Transitions of care, discharge medication reconciliation, discharge 
medication education, pneumonia, med errors, formulary
Introduction
Patients admitted to the hospital with a diagnosis of pneumonia are at high risk for 
readmission. In 2012, the Affordable Care Act established the Hospital Readmission 
Reduction Program, which requires the Centers for Medicare and Medicaid Services 
(CMS) to reduce payments to hospitals with excess readmissions. Applicable condi-
tions, including heart failure, myocardial infarction, and pneumonia, are penalized for 
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unplanned readmissions within 30 days 
of hospital discharge.1 As a result, many 
hospitals are expanding transitions of 
care (ToC) services to optimize discharge 
planning and medication management. 
Unintended medication discrepancies 
during ToC have contributed to 
adverse drug events and may play 
a role in hospital readmissions.2 A 
medication reconciliation pilot at John 
Hopkins Hospital found that 40% of 
patients had at least one unintended 
discrepancy on hospital admission 
or discharge. Twenty-nine percent of 
those discrepancies had the potential 
to result in moderate or severe adverse 
drug events.3 To address medication 
safety, The Joint Commission has 
implemented National Patient Safety 
Goal 03.06.01 to guide hospitals in 
maintaining and communicating 
accurate patient medication 
information.4 The Joint Commission 
defines medication reconciliation as 
comparing medications the patient 
is or should be taking to newly 
prescribed medications, and resolving 
discrepancies. Specific elements 
of performance are provided to 
perform complete and comprehensive 
medication reconciliation. 
At our institution, a service line of ToC 
pharmacists was introduced in 2012 to 
reduce readmissions and medication 
errors in our high risk cardiac and general 
medicine patient populations. The role 
of this pharmacist includes reviewing 
prior to admission medication histories, 
performing medication reconciliation, 
identifying and addressing barriers 
to discharge, reviewing discharge 
medications, and providing discharge 
medication education to the patient 
and/or family/caregivers. Pharmacist 
interventions are prioritized for high-
risk patient populations, including 
patients with high-risk medications, 
polypharmacy, and high-risk disease 
states, including pneumonia. 
As part of a hospital-wide initiative to 
reduce pneumonia readmission rates 
at our institution, an interdisciplinary 
collaborative effort was created between 
physicians and ToC pharmacists to opti-
mize medication regimens for pneumonia 
patients on hospital discharge. While 
there is data available on the impact of 
ToC pharmacists in reducing medica-
tion errors and readmission rates in the 
general population, there is very limited 
data focusing on outcomes in pneu-
monia patients. Given the high risk for 
readmission in this patient population, 
the reimbursement penalty for excess 
readmissions, and the changes to patient 
medications on hospital admission and 
discharge, it is prudent and important 
to evaluate the incidence of medication 
errors and the outcomes associated with 
implementing ToC interventions.5 The 
purpose of this study was to describe the 
impact of ToC pharmacists in identi-
fying and reducing medication errors on 
discharge for pneumonia patients. 
Methodology
Intervention
Pharmacists participated in a daily sign 
off with the general medicine teams to 
identify all admitted pneumonia patients 
and begin preparing their medication 
list in anticipation of discharge. Patients 
admitted with a diagnosis of pneumonia 
may have many changes to their home 
medication regimens, not limited to: 
prescription of new antibiotics, renal dose 
adjustments to existing medications, and 
changes to anticoagulation, blood pres-
sure or diabetic regimens, which may be 
held or adjusted during their hospital stay. 
Upon discharge, medication lists were 
evaluated for accuracy and completeness. 
In addition to evaluating the accuracy 
of medication lists, ToC pharmacists 
and physicians collaborated to ensure 
patients had appropriate follow-up visits, 
and to address any access or formulary 
issues which may prevent the patient 
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from picking up their medication post 
discharge. This included completing 
prior authorizations, checking for stock 
of medication, and arranging medication 
delivery to bedside before discharge when 
appropriate. Patients were educated by the 
ToC pharmacist on their medications and 
follow up instructions before discharge. 
Study Design
To evaluate the impact of this 
intervention, a retrospective chart 
review was conducted on all patients 
discharged with a diagnosis of 
pneumonia between December 2015 
to February 2016. Our institution uses 
the Epic (Verona, Wisconsin) electronic 
medical record system, which allows for 
tracking of pharmacist interventions, 
as well as documentation of patient 
medication education provided. Patients 
were stratified based on whether they 
had documented ToC pharmacist 
medication review before discharge vs. 
standard of care (medication teaching 
by nursing before discharge with no 
additional medication review). Baseline 
characteristics were compared between 
the two groups (Table 1).
Medication errors were identified 
by comparing the patient discharge 
medication list to the physician discharge 
summary, before admission and inpatient 
medication lists. For patients discharging 
to home with or without home health, 
the after visit summary (AVS) medication 
list, which is provided to the patient on 
discharge, was assessed for medication 
errors. For patients discharged to a 
skilled nursing facility (SNF) or another 
healthcare facility, an interagency form 
was assessed for medication errors. This 
form, which includes a complete and 
updated list of discharge medications, is 
generated by Epic and provided to the 
receiving facility at the time of patient 
transfer. Patient-specific treatment plans, 
labs, vitals and diagnostic exams were 
also taken into consideration in assessing 
the appropriateness of therapy. 
Outcomes and  
Statistical Analysis
The primary objective of this study was 
to describe the incidence of medication 
errors in pneumonia patients and to 
evaluate the impact of the ToC phar-
macist in reducing medication errors. 
The secondary objective was to describe 
the pharmacist interventions made for 
patients who received ToC pharmacist 
interventions. Errors rates were compared 
between the standard of care group and 
the pharmacist intervention group, and 
statistical analysis was performed using 
the chi-square test. Errors were strati-
fied by error type and separated into the 
following categories: prescription of 
incorrect medications (wrong drug, 
Baseline Characteristics Pharmacist Intervention 
(N = 69)
No Pharmacist Intervention  
(N = 56)
P Value
Age 72 (SD: 18) 69 (SD: 21) 0.479
Male 42% 39.28% 0.728
Duration of stay 4 days 4 days 0.726
Discharge disposition
Home 56 34 0.01208
Skilled nursing facility 13 18 0.0687
Hospice 0 2 0.093
Long term care facility 0 1 0.238
Acute rehab 0 1 0.238
Antibiotics on discharge 82.6% 53.57% 0.00044
Type of Pneumonia
Community acquired pneumonia 20 5 0.0054
Healthcare-associated pneumonia 4 4 0.787
Aspirational pneumonia 11 7 0.6455
Viral pneumonia 4 1 0.285
Pneumonia: Unspecified 25 26 0.267
Possible pneumonia 3 8 0.0549
Necrotizing pneumonia 1 0 0.375
Fungal pneumonia 1 0 0.375
Ventilator-associated pneumonia 0 2 0.093
Other 0 3 0.0601
Table 1. Baseline Characteristics
Original Research
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strength, dosage, or frequency), missing 
or incomplete instructions, duplicate 
medications or therapeutic class, and 
missing or omitted medications. Addi-
tionally, for patients who did receive 
pharmacist medication review at the time 
of hospital discharge, the interventions 
made by ToC pharmacists were quanti-
fied and documented. The severity of 
errors was classified as mild, moderate or 
severe based on the American Society for 
Healthcare Risk Management (ASHRM) 
criteria.6 Errors were assessed individu-
ally by two ToC pharmacists who were in 
agreement for all identified errors.
This study received Institutional Review 
Board Approval #37647. The statis-
tical analysis for categorical data was 
performed using chi-square statistical 
test, while numerical data was analyzed 
using t-test with an alpha of 0.05.
Results
A total of 125 patients were discharged 
with pneumonia during the study 
period. Sixty-nine patients' medication 
lists were reviewed by ToC pharmacists, 
while 56 patients received standard of 
care. In the ToC intervention group, 
five patients had discrepancies on their 
medication list during chart review, 
which equates to an error rate of 7.2%. 
In the standard of care group, 36 patients 
had medication errors, which equates 
to an error rate of 64.3%. The difference 
was statistically significant (P < 0.00001) 
and corresponds to an 88.8% relative 
decrease in medication errors (Table 2).
In the total patient population, 95 errors 
were identified. Amongst patients who 
received standard of care, or nursing 
medication education at bedside, 89 
medication errors were identified for 
56 patients. On average, there were 1.6 
errors per patient, and 47% of errors in 
this group resulted from prescription of 
incorrect medications. This was identi-
fied as having an incorrect medication 
prescribed, having an incorrect dose or 
frequency defined, or having a significant 
drug interaction that would affect the 
appropriateness of therapy. Twenty-one 
percent of errors were missing instruc-
tion errors which included missing 
dose, frequency, or route, and 16% of 
errors were omission errors in which 
a medication was unintentionally not 
prescribed. The remaining 16% of errors 
were duplicate medication or duplicate 
therapeutic class errors (Table 2). Errors 
were classified as mild (45%) in severity, 
moderate (46%), and severe (9%). While 
67% of errors were identified in patients 
discharged to home, 33% of errors were 
identified in patients discharged to a SNF. 
In the ToC intervention group, six 
medication errors were identified for 
69 patients. On average, there were 0.09 
errors per patient. Four errors (67%) 
 Classification of Errors Pharmacist Intervention 
Group (N = 69)
Standard of Care Group  
(N = 56)
Number of patients with error 5 (7.2%) 36 (64.3%)
Total number of errors 6 89
Error Type
Incorrect medication 4 42
Missing Instructions 0 19
Omission 2 14
Duplicate medication 0 14
Error Severity
Mild 4 40
Moderate 2 41
Severe 0 8
Error by Discharge Disposition
Patients discharging home with errors 1 24
Patients discharging to SNF with errors 4 12
Antibiotic Prescribing
Number of patients prescribed antibiotics 57 30
Number of patients with antibiotic-related error 1 5
Table 2. Classification of Errors
Original Research
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were incorrect medication errors, and 
two errors (33%) were omission errors 
(Table 2). Errors were classified as mild 
(67%) and moderate (33%) in severity. 
Twenty percent of errors were identified 
in patients discharged to home while 
80% of errors were identified in patients 
discharged to a SNF. 
During this time period, the ToC 
pharmacist also documented 71 
interventions, which were made before 
the patient’s discharge. Thirty-one 
interventions were documented which 
involved resolving access or formulary 
issues, including resolving insurance 
issues. Twenty-three interventions 
addressed incorrect medication, dose or 
frequency issues. Twelve interventions 
addressed omitted medications, and 
five interventions addressed duplicate 
medications or therapeutic classes.
Discussion
We are the first to our knowledge to show 
that patients admitted with a pneumonia 
diagnosis would benefit from ToC inter-
ventions, including discharge medication 
reconciliation. With the focus on patient 
safety, many organizations, including 
The Joint Commission, place significant 
emphasis on medication reconciliation 
around ToC. This study provides statisti-
cally significant data in advancing and 
showing the importance of pharmacist 
involvement in comprehensive patient 
care, especially in the reduction in medi-
cation errors. Many studies may show a 
need for medication reconciliation, but 
there is limited literature on the phar-
macist affecting outcomes of pneumonia 
patients. The results show clear evidence 
that during the complex situation of a 
patient’s discharge or transfer of care, 
medication errors do occur (33% in 
this study). ToC pharmacists show a 
significant benefit in ensuring the correct 
medication are ordered/prescribed for 
patient safety.
Overall, the baseline characteristics 
were balanced between the two groups, 
including age, gender, and length of stay. 
The ToC group had a larger percentage 
of patients discharged on an antibiotic, as 
compared to the standard of care group 
(82.6% vs. 53.6%, p < 0.001). This may be 
attributed to the high-risk criteria used by 
our ToC program to triage patients, which 
includes prioritizing patients discharging 
on an antibiotic. Patients who already 
completed their course of antibiotics 
during their admission were lower priority 
for being seen by the ToC pharmacist. 
However, the majority of errors identified 
were unrelated to antibiotic prescribing 
minimizing potential for apparent bias 
(Table 2). Additionally, the ToC group 
also had a larger population discharged to 
home, as opposed to SNF or other assisted 
care facilities (81.2% vs. 60.7%, p = 0.01). 
This is also by design as the ToC program 
prioritizes patients discharging home 
over those discharging to a facility, due to 
a greater perceived benefit based on the 
assumption that patients discharging to an 
acute care facility will have medications 
managed by healthcare personnel. 
However, since the patients discharging 
to SNF did have a high rate of error, this 
would not create any favorable benefit 
in reporting error rates. This distinction 
is also unique as most of the previous 
literature for ToC programs focused on 
patients discharging to the home setting. 
This study sheds light on the complexity of 
other dispositions as well.
While patients seen by the ToC pharma-
cist at discharge had significantly fewer 
errors compared to the standard of care 
group, the majority of errors identi-
fied in the ToC group were in patients 
discharging to a SNF. The significance of 
a higher error rate in patients discharged 
to a SNF speaks to the overall discharge 
process in this patient population. At 
the time of discharge, the patient’s nurse 
generates and prints an “interagency 
form” which should be provided to the 
nursing facility and is accepted as the 
primary source of updated medications. 
However, if this list is printed too early, 
and additional changes are made to the 
patient's medication list by the team, 
the nursing facility may be provided 
with an outdated medication list. This is 
further complicated by placement issues 
that may arise and lead to unexpected 
delays to patient discharge. In many 
cases, the patient may stay hours to days 
longer than originally anticipated. Upon 
discharge, a new medication list should 
be, but is not always, generated. For the 
SNF patients seen by the ToC pharmacist, 
all errors identified in chart review were 
due to medication changes made to the 
list after pharmacist review. There is room 
for improvement in interdisciplinary 
communication as well as the overall 
discharge process when patients are tran-
sitioning to a SNF.
The majority of medication errors 
were identified in patients who were 
not seen by the ToC pharmacist at the 
time of discharge. A common cause of 
discharge errors was related to incorrect 
medication reconciliation on admission. 
This highlights the importance of 
comprehensive and complete medication 
reconciliation on admission, as it relates 
to reducing discharge medication errors. 
For example, if an incorrect dose or 
frequency was entered on admission, it 
is generally then incorrectly resumed on 
discharge as well. A frequent source of 
duplicate medication errors was due to 
therapeutic interchange on admission due 
to formulary restrictions. For example, 
a patient may have their ACE inhibitor 
changed to an alternative within the 
same class once admitted, and then 
both medications would be incorrectly 
resumed on discharge. Another source 
of error was an appropriate de-escalation 
of antibiotics on discharge. The ToC 
pharmacist evaluates cultures, renal 
function, and days’ supply in ensuring 
appropriateness of therapy. For patients 
November/December 2017   California Journal of Health-System Pharmacy     cjhp     201
Original Research
de-escalated from IV to oral antibiotics 
on discharge, errors were identified in 
patients who did not receive a sufficient 
supply or who did not have renally-
adjusted regimens. Another source 
of errors was related to unintentional 
omission of medications. Many of 
the patients had their blood pressure 
regimens held on admission due to 
hypotension secondary to sepsis. On 
discharge, the medications were not 
resumed despite resolution of the 
hypotension. Lastly, insulin regimens 
were also frequently altered in the 
hospital and incorrectly resumed on 
discharge not taking into account other 
changes like a new steroid regimen. 
Many of these errors were specific to 
health status changes associated with a 
pneumonia admission and highlight the 
importance of comprehensively assessing 
patient medication during ToC following 
a pneumonia admission. 
In classifying errors based on severity, 
there were no severe errors in the ToC 
intervention group. The standard of care 
group had primarily mild and moderate 
errors although there were severe errors 
identified as well. Mild errors had 
minimal potential for harm, such as the 
omission of an over-the-counter medica-
tion. Moderate errors had the potential 
for adverse effects but would not severely 
affect quality of life, such as incorrect 
dosing of a blood pressure medication or 
an inhaled corticosteroid. Severe errors 
had potential for severe harm, such as 
incorrectly dosing anticoagulants, which 
was seen in several patients. 
In the ToC intervention group, we 
evaluated interventions the pharmacist 
provided at the time of patient discharge. 
44% of our interventions were resolving 
access or formulary issues. Clinical phar-
macists at our institution participate in 
daily team care rounds with physicians, 
nurses and case managers, to anticipate 
and address barriers to discharge. We 
assisted with identifying medications 
that would have a high copayment or 
The ToC pharmacist 
interventions 
reduced medication 
discrepancies and 
increased the rate of 
accuracy for patients 
admitted with a 
diagnosis of pneumonia. 
require prior authorization, as well as 
ensuring or securing stock of medi-
cation, and coordinating delivery to 
bedside when appropriate. A significant 
portion of our interventions revolved 
around ensuring our patients were able 
to access their medications on discharge, 
so as not to delay discharge or increase 
the risk of readmission. 
While the primary outcome of this study 
evaluated the impact of ToC pharmacists 
in reducing medication errors, there was 
tremendous value in collaborating with 
physicians to anticipate and plan for 
discharge. Typically, the ToC pharmacist 
is notified when discharge orders are 
placed for a patient and has limited time 
to review the medication list, educate 
the patient, and resolve any medication-
related issues. Daily sign off allowed 
the pharmacist to anticipate discharges 
in advance, which provided time to 
coordinate teaching with the patient 
and caregivers or family members, 
review the medication list for medica-
tions which might be problematic for 
insurance claims, as well as collaborate 
with the physicians to set up any follow 
up appointments for acute or chronic 
disease states identified during their 
hospital admission. 
The ToC pharmacist interventions 
reduced medication discrepancies and 
increased the rate of accuracy for patients 
admitted with a diagnosis of pneumonia. 
Future studies would benefit from further 
evaluating the impact of interdisciplinary 
efforts in optimizing ToC. While our 
results did not focus on cost savings or 
readmission rates, we hope that future 
research is able to address how ToC phar-
macist interventions can be translated 
into favorable outcomes in readmission 
reduction and health care cost savings 
related to medication error, discharge 
delays, and excessive readmissions. 
At our institution, we expanded our 
ToC pharmacist services to include a 
dedicated pharmacist for our high-risk 
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medicine patients, including pneumonia 
patients. We continue to collaborate with 
our medicine teams to plan for discharge 
and participate in daily interdisciplinary 
rounds to anticipate and address patient-
specific needs during ToC. 
Limitations
Limitations of our study were that it 
was conducted as a retrospective chart 
review in a single academic medical 
center. While randomized controlled 
trials are the gold standard, it would 
not have been ethical to intentionally 
withhold care to a subset of our patient 
population who would benefit from 
pharmacist medication review, based 
on our ToC program criteria. However, 
the two groups were overall similar in 
baseline characteristics. At the time of 
this study, our service was comprised of 
two pharmacists, and our workflow was 
limited by staffing and rolling discharges. 
Therefore, despite our best attempt to 
see all patients who meet our program 
criteria, patients could still discharge 
without pharmacist medication review 
or education. Additionally, our study was 
conducted over a shorter period with 
a relatively small patient population. 
However, statistically significant results 
were demonstrated. Future steps 
should expand upon this research to 
evaluate the impact of ToC pharmacist 
interventions and medication error 
reduction on readmission rates and 
hospital-related costs. 
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Conclusion
To our knowledge, this is the first study 
to show the importance of pharmacist 
involvement in reducing medication 
errors in pneumonia patients on hospital 
discharge. The ToC pharmacist inter-
ventions demonstrated a clinically 
and statistically significant decrease 
in medication discrepancies, as well 
as an increased rate of accuracy of the 
discharge medication list. The ToC 
pharmacists most documented interven-
tions included identifying and resolving 
access or formulary issues and incorrect 
frequency, dose, or duration of therapy. 
Continued metrics and interventions are 
being collected to assess the impact of the 
ToC pharmacist on patient outcomes. o 
